与代谢功能障碍相关的脂肪性肝病中的骨髓缩症:从机制到管理
Aili Fan1,2, Jie Zhang3, Qing Ye3
1Department of Gastroenterology/Hepatology, Tianjin University Central Hospital/The Third Central Hospital Affiliated with Nankai University, Tianjin, China.
Frontiers in endocrinology
|December 29, 2025
概括
骨质疏松症和骨质疏松症结合在一起的骨质疏松症和骨质疏松症是与代谢功能障碍相关的脂肪性肝病 (MASLD) 中越来越令人担忧的疾病. 早期发现和综合治疗对于改善MASLD患者的骨,肌肉和肝脏健康至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 老年病的医生 老年病的医生
- 肌肉骨医学 肌肉骨医学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 越来越多地与肌肉骨问题有关.
- 骨质疏松症和肉,在MASLD中单独研究,经常作为骨质疏松症共存.
- 在MASLD患者中,骨质缩症的综合影响和管理是未被充分认识到的.
研究的目的:
- 审查MASLD的流行病学,病理生理学,临床相关性和骨髓缩症的管理.
- 突出导致肝脏和肌肉骨疾病的共同机制.
- 强调需要主动查和综合治疗策略.
主要方法:
- 文献综述综合了关于骨质沙症和MASLD的当前研究.
- 分析共享的致病途径,包括胰岛素抵抗,炎症,荷尔蒙失衡和肠道失调.
- 讨论诊断标准和治疗干预措施.
主要成果:
- 共享的病理生理路径创造了一个循环,加剧了MASLD和骨髓缩症.
- 胰岛素抵抗,慢性炎症,荷尔蒙变化和肠道功能失调是关键的因素.
- 建议采用多维治疗方法.
结论:
- 骨髓缩症是MASLD的一个严重并发症,需要临床治疗.
- 积极的查和标准化的评估对于早期诊断至关重要.
- 针对营养,运动,药物治疗和代谢/肠道健康的综合治疗策略可能会改善患者的治疗结果.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
165
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
165
Overview of Lipid Metabolism
4.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.7K
Chronic Pancreatitis II: Collaborative Care
284
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
284
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
153
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
153
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
197
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
197
Ultrasound II: Endoscopic Ultrasound and FibroScan
489
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
489


